Top compounds associated with response to CSF2


Feature Type Standardized
Nominal ANOVA
mRNA LY317615 GDSC1000 pan-cancer AAC 0.0055 0.9
mRNA tamatinib CTRPv2 pan-cancer AAC -0.0062 0.9
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.006 0.9
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.0087 0.9
mRNA TAE684 GDSC1000 pan-cancer AAC -0.0086 0.9
mRNA Irinotecan FIMM pan-cancer AAC 0.018 0.9
mRNA ifosfamide CTRPv2 pan-cancer AAC 0.0086 0.9
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.0054 0.9
mRNA StemRegenin 1 CTRPv2 pan-cancer AAC -0.0055 0.9
mRNA Bexarotene FIMM pan-cancer AAC 0.023 0.9
Download CSV